Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-25-000019

Options or other derivatives

  • Director acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Martin Christopher Nathan · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-11 Grant or award : show line 1 in the form Stock Option (right to buy) +35,000 35,000 D
Loading xslF345X05/form4.xml…